Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Chronic Kidney Diseases, Hypertension, Cardiovascular Diseases
In brief
This work aims to evaluate the effects of the association of green propolis extract with royal jelly on inflammation and oxidative stress in participants with chronic kidney diseases (CKD) and Systemic arterial hypertension (SAH), in a longitudinal, randomized, double-blind, placebo-controlled clinical trial that will be carried out for 2 months.
Key facts
- Study ID
- NCT06288204
- Run by
- Universidade Federal Fluminense
- People needed
- 153
- Starts
- 2024-10-01
- Expected to finish
- 2027-07-31
- Last updated by the study team
- 2026-05-15
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients in stages 3 and 5 of CKD (GFR from 15 to 59 mL/min),
- patients receiving ambulatorial nutrition treatment at least 6 months
- patients on regular Hemodialysis treatment for at least 6 months
- patients using one to three antihypertensive drugs
You may not qualify if…
- autoimmune and infectious diseases,
- diabetes
- cancer
- AIDS
- pregnant women
- patients using catabolic drugs or antibiotics;
- patients with catheter access to hemodialysis;
- patients using antioxidant vitamin supplements, prebiotics, probiotics, symbiotic,
- Patients on regular intake of propolis who are allergic to corn starch or report being allergic to bee stings.
- patients with acute myocardial infarction (AMI) and/or cerebrovascular accident (CVA)
Where it is running
- Denise Mafra — Rio de Janeiro, Rio de Janeiro, Brazil (enrolling)
- Denise Mafra — Rio de Janeiro, Rio de Janeiro, Brazil (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.